BackBristol-Myers Squibb Company Overview

Bristol-Myers Squibb Company Inventory

Latest inventory for BRM.DE: $2.7B.

Get informed when a big investor buys or sells

+ Follow
Inventory
$2.74B

Peer trimmed avg / median

Loading

Bristol-Myers Squibb Company Inventory History

Loading

Bristol-Myers Squibb Company vs. peers: Inventory Comparison

Loading

Bristol-Myers Squibb Company Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bristol-Myers Squibb Company (BRM.DE) FAQ

Bristol-Myers Squibb Company (BRM.DE) currently reports a inventory of $2.7B as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Bristol-Myers Squibb Company's inventory history and peer comparisons.

Bristol-Myers Squibb Company's inventory changed from $0 to $2.7B (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bristol-Myers Squibb Company reported $2.7B in inventory as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $2.7B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bristol-Myers Squibb Company, and consider following BRM.DE for alerts when major investors trade the stock.

Bristol-Myers Squibb Company is classified in the Healthcare sector. On inventory, it currently shows $2.7B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BRM.DE with unrelated industries.